US Patent Issued to QUEST DIAGNOSTICS INVESTMENTS on July 21 for "Method for non-invasive prenatal screening for aneuploidy" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,888, issued on July 21, was assigned to QUEST DIAGNOSTICS INVESTMENTS LLC (Secaucus, N.J.).

"Method for non-invasive prenatal screening for aneuploidy" was invented by Charles Rowland (San Juan Capistrano, Calif.), Renius Owen (San Juan Capistrano, Calif.), Charles Strom (San Juan Capistrano, Calif.) and Ke Zhang (San Juan Capistrano, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for non-invasive prenatal screening (NIPS) of fetal aneuploidies. The present methods are based on analyzing cell-free fetal DNA (cff DNA) found in a pregnant woman's circulation through the next generation sequencing (NGS) te...